Clinical OMICS

MAY-JUN 2018

Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine

Issue link:

Contents of this Issue


Page 41 of 51

40 Clinical OMICs May/June 2018 is a blockchain-based AI platform that enables deep learning computations on quantified biology for personal health insights. The platform connects people, data scientists and research sponsors to develop predictive models. "I can- not think of a bigger mission for healthcare than to unlock people's medical data through the establishment of a cryp- toasset economy using the most advanced market weap- ons at our disposal: machine learning, precision medicine (OMICs), distributed ledger technology, applied cryptogra- phy, and edge computing. It is the only strategy whereby a seller 's market will eventually become a buyer 's market," said Walter De Brouwer, Ph.D., company CEO. "Anything not exposed to the free market is mispriced. So are the mil- lions of biomarkers in people's bodies. They have a market price, but it is waiting for a medium of exchange to become a store of value. Medical data will become a financial asset." From blockchain technology, artificial intelligence, and deep learning to new sequencing technologies and telehealth, these fledgeling U.S.-based companies are poised to make significant impacts in the precision medicine and multi- omics world of the future. U.S.Startups to Watch 10 Headquarters: Palo Alto, California. Year Founded: 2016. Company Founders: Walter De Brouwer, Ph.D., Sam De Brouwer, Alan Greenem, M.D., Cheryl Greene, Anthea Chung. Employees: 15. Major Investors: Comet Labs, Pantera Capital. a-r-t-i-s-t / Getty Images

Articles in this issue

Links on this page

Archives of this issue

view archives of Clinical OMICS - MAY-JUN 2018